American researchers have identified a single enzyme in Toxoplasma gondii, the parasite responsible for toxoplasmosis, whose inactivation can significantly reduce its virulence. This discovery opens up new possibilities for treating toxoplasmosis and potentially other infectious diseases.
November 2002
Contrary to previous concerns, a study conducted at the University of California, San Diego, suggests that raloxifene, a drug used to treat osteoporosis, does not appear to elevate the risk of heart problems in women with cardiovascular disease. This finding provides reassurance regarding the drug's safety profile.
November 2002
Researchers at Johns Hopkins University report that an experimental substance called C75 has demonstrated appetite-suppressing effects and led to rapid weight loss in obese mice. While promising, further research is needed to evaluate its safety and efficacy in humans.
November 2002
A survey of over 2,000 diabetics in the United States reveals that the majority are unaware of the increased risk of cardiovascular disease associated with diabetes. This highlights the need for improved education and awareness campaigns targeting diabetic patients.
November 2002
A study from Erasmus University suggests that moderate alcohol consumption may lower the risk of peripheral artery disease by reducing the formation of blood clots in the leg arteries. This adds to growing evidence of potential cardiovascular benefits associated with moderate alcohol intake.
November 2002
Consuming sufficient folates may lower the risk of colorectal cancer in women, according to a study published in the International Journal of Cancer. This highlights the potential protective effects of dietary folates against colorectal cancer development.
November 2002
A review of studies conducted in Western nations reveals that one in seven prisoners suffers from a serious mental illness. This underscores the need for improved mental health care within prison systems to address this significant public health concern.
November 2002
Two studies published in The New England Journal of Medicine suggest that reducing body temperature is beneficial for protecting the brains of patients who have experienced cardiac arrest, highlighting the importance of therapeutic hypothermia in improving outcomes.
November 2002
Laboratory-developed leptin, known as the 'obesity hormone,' has demonstrated significant improvements in metabolic abnormalities among lipodystrophy patients in a recent study involving nine participants. This finding suggests a potential therapeutic avenue for managing this rare metabolic disorder.
November 2002
Researchers at Temple University suggest that a common virus may contribute to the development of medulloblastomas, the second most common type of childhood brain tumor. This finding could lead to new insights into the prevention and treatment of this deadly disease.
November 2002